Information date: 29 September 2026 — This template governs appointment, exclusivity, territory, pricing, minimum purchase, trademark use, confidentiality, term and post-termination sell-off. The review point is that exclusivity is only as strong as the performance floor and territory definition attached to it, while the post-termination survival clauses decide who keeps the customer list, pipeline, stock and warranty obligations after exit. Knowing that statement is not enough for an operating, research or compliance decision. The team must first establish who and what it applies to, how the effect reaches the real process, and which evidence would justify action.
Verified facts and scope
This template governs appointment, exclusivity, territory, pricing, minimum purchase, trademark use, confidentiality, term and post-termination sell-off. The review point is that exclusivity is only as strong as the performance floor and territory definition attached to it, while the post-termination survival clauses decide who keeps the customer list, pipeline, stock and warranty obligations after exit.
Confirm first: is the Chinese counterparty a reseller (buy-sell) or an agent (commission), who invoices the end customer, how VAT and export documents flow, its registered address and business scope, whether territory means provinces, cities or named key accounts, and whether the parties want PRC law with CIETAC or SHAC arbitration rather than a foreign seat.
How the effect reaches operations
Territory and exclusivity promises are priced by the obligations attached to them: minimum purchase, marketing spend, reporting and audit rights, and a cure-and-downgrade mechanism. Without those, the clause is a one-way restriction. Post-termination wording is enforced as written, so silence on stock, spares and warranty means the distributor can keep pipeline claims and inventory risk on your books.
Granting province-wide exclusivity for three or more years with no minimum purchase, no cure period and no audit right freezes the market against you. Resale price maintenance or absolute territorial bans can also conflict with PRC competition rules. Treating a distributor as an agent, or vice versa, shifts tax, invoicing and product-liability exposure.
For “China Distributor Agreement Template Review: Exclusivity, Territory and Post-Termination Clauses”, official rules or published findings, direct evidence from the relevant product or process, and assumptions that remain untested should be recorded separately. A broad source defines the external boundary; it does not replace batch records, protocols, contracts, labels or direct observations.
Decision
If volumes are unproven, start non-exclusive for 12 months and make exclusivity automatic only on hitting a stated minimum purchase with a 60-day cure. If a distributor insists on long exclusivity, trade it for a performance floor, a territory carve-out for named key accounts, and an express post-termination buy-back at defined prices.
Implementation checklist
- Map who invoices the end customer before drafting exclusivity.
- Attach a minimum-purchase schedule with cure and downgrade rights.
- Write post-termination stock, spares, warranty and trademark wind-down terms.
- Assign one decision owner, one implementation owner and a dated review point for “China Distributor Agreement Template Review: Exclusivity, Territory and Post-Termination Clauses”.
- For “China Distributor Agreement Template Review: Exclusivity, Territory and Post-Termination Clauses”, archive the source page, access date, applicable population or entity, and internal evidence both supporting and opposing the current decision.
- When a rule, formulation, supplier, protocol or observed result changes, reopen only the affected question in “China Distributor Agreement Template Review: Exclusivity, Territory and Post-Termination Clauses”.
Evidence and review
For “China Distributor Agreement Template Review: Exclusivity, Territory and Post-Termination Clauses”, start with one real case rather than an abstract checklist. Record the input version, responsible owner, start time, observed result and stop condition. If the team cannot complete “Map who invoices the end customer before drafting exclusivity.” with current evidence, it should not expand the process to more products, patients, suppliers or markets. The first review should focus only on facts capable of changing the decision.
The second control follows “Attach a minimum-purchase schedule with cure and downgrade rights.”. Keep the source date, applicable population or entity, deadline, cost effect and owner in the same evidence file. A wording preference does not justify a new version. A repeated discrepancy, an unsupported health claim or a regulatory mismatch does: correct that point and hold release until the evidence is available.
After “Write post-termination stock, spares, warranty and trademark wind-down terms.”, compare the intended outcome with what actually happened. Apply the same success criteria to each later expansion. If only one number, date or responsibility changes, update that field and the affected conclusion instead of recreating evidence that remains valid. This keeps the decision traceable without turning review into an open-ended rewrite cycle.
Limits of the conclusion
This is a review framework, not legal advice. Enforceability depends on the signed text, the applicable law and the chosen arbitration seat, and should be confirmed with PRC-qualified counsel.
